Service d'endocrinologie, Diabétologie et maladies métaboliques, CHU de bordeaux, Avenue Magellan 33600, Pessac, France.
Service d'endocrinologie, Diabétologie et maladies métaboliques, CHU de bordeaux, Avenue Magellan 33600, Pessac, France; INSERM and University of Bordeaux, Neurocentre Magendie, U1215, France.
Best Pract Res Clin Endocrinol Metab. 2020 Mar;34(2):101381. doi: 10.1016/j.beem.2020.101381. Epub 2020 Jan 30.
Overt Cushing's syndrome is a severe condition responsible for multiple comorbidities and increased mortality. Effective treatment is essential to reduce mortality, improve comorbidities and long-term quality of life. Surgical resection of the causal lesion(s) is generally the first-line and most effective treatment to normalize cortisol secretion. Adjunctive symptomatic treatments of co-morbidities are often necessary both during the active phase of the disease and for persisting co-morbidities after cessation of hypercortisolism. Second-line treatments include various pharmacological treatments, bilateral adrenalectomy, and radiotherapy of corticotroph tumors. The choice of these treatments is complex, must be performed in a multidisciplinary expert team to be individualized for each patient, and use a shared decision-making approach.
库欣综合征是一种严重的疾病,可导致多种合并症和死亡率增加。有效的治疗对于降低死亡率、改善合并症和长期生活质量至关重要。手术切除病因病变通常是使皮质醇分泌正常化的一线和最有效的治疗方法。在疾病的活动期和皮质醇增多症停止后持续存在的合并症期间,通常需要辅助治疗合并症的症状。二线治疗包括各种药物治疗、双侧肾上腺切除术和促肾上腺皮质细胞瘤的放射治疗。这些治疗方法的选择很复杂,必须在多学科专家团队中进行,针对每个患者进行个体化治疗,并采用共同决策方法。